Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,324
Sort by:
US Cancer Diagnostics Market Segmentation Analysis 2017-2021: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 9,800.00
... tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
December 2017
620 pages
US Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2017-2021: Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 9,700.00
... potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist ... key suppliers. Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment ...
December 2017
465 pages
Immunohematology and Infectious Disease NAT Screening Market: 2017 Supplier Sales and Market Shares by Country, Technology Review, and Strategic Profiles of Leading Suppliers
US$ 3,850.00
This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...
December 2017
154 pages
Global Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2017-2021: France, Germany, Italy, Japan, Spain, UK, US--Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 35,500.00
... entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and ... country. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with ...
December 2017
775 pages
Europe Cancer Diagnostics Market Segmentation Analysis 2017-2021: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ... laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business ...
December 2017
820 pages
Immunodiagnostics Market Forecast 2017-2021: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
US$ 24,500.00
Complete report $24,500 DataPack (test volumes, sales forecasts, supplier shares)$15,900. This comprehensive seven-country report contains ... technologies and products by test. Worldwide Market Overview Estimates of facilities performing clinical chemistry and immunodiagnostic tests by country. Test volume and ...
December 2017
1115 pages
